×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CDNA – caredx, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CDNA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
6/3
04:38 pm
cdna
CareDx Announces Repurchase of 5% of Outstanding Shares [Yahoo! Finance]
High
Report
CareDx Announces Repurchase of 5% of Outstanding Shares [Yahoo! Finance]
6/3
04:30 pm
cdna
CareDx Announces Repurchase of 5% of Outstanding Shares
High
Report
CareDx Announces Repurchase of 5% of Outstanding Shares
5/22
09:27 am
cdna
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
Low
Report
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
5/21
08:48 pm
cdna
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
Low
Report
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
5/13
04:01 pm
cdna
CareDx to Participate in Upcoming Investor Conferences
Low
Report
CareDx to Participate in Upcoming Investor Conferences
5/5
11:08 pm
cdna
CareDx, Inc (NASDAQ: CDNA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Medium
Report
CareDx, Inc (NASDAQ: CDNA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
5/5
09:26 am
cdna
CareDx, Inc (NASDAQ: CDNA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $40.00 price target on the stock.
Low
Report
CareDx, Inc (NASDAQ: CDNA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $40.00 price target on the stock.
5/5
08:11 am
cdna
CareDx, Inc (NASDAQ: CDNA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Low
Report
CareDx, Inc (NASDAQ: CDNA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
6/20
04:30 pm
cdna
Form 4 CareDx, Inc. For: Jun 17 Filed by: Maag Peter
Low
Report
Form 4 CareDx, Inc. For: Jun 17 Filed by: Maag Peter
6/18
04:27 pm
cdna
Form 144 CareDx, Inc. Filed by: Valantine Hannah
Low
Report
Form 144 CareDx, Inc. Filed by: Valantine Hannah
6/17
04:56 pm
cdna
Form 4 CareDx, Inc. For: Jun 13 Filed by: Goldberg Michael
Low
Report
Form 4 CareDx, Inc. For: Jun 13 Filed by: Goldberg Michael
6/17
04:35 pm
cdna
Form 4 CareDx, Inc. For: Jun 13 Filed by: Cohen Fred E
Low
Report
Form 4 CareDx, Inc. For: Jun 13 Filed by: Cohen Fred E
6/17
04:32 pm
cdna
Form 4 CareDx, Inc. For: Jun 13 Filed by: Maag Peter
Low
Report
Form 4 CareDx, Inc. For: Jun 13 Filed by: Maag Peter
6/17
04:31 pm
cdna
Form 4 CareDx, Inc. For: Jun 13 Filed by: Riggsbee Richard Bryan
Low
Report
Form 4 CareDx, Inc. For: Jun 13 Filed by: Riggsbee Richard Bryan
6/17
04:30 pm
cdna
Form 4 CareDx, Inc. For: Jun 13 Filed by: Bickerstaff George
Low
Report
Form 4 CareDx, Inc. For: Jun 13 Filed by: Bickerstaff George
6/17
04:30 pm
cdna
Form 4 CareDx, Inc. For: Jun 13 Filed by: TORRES ARTHUR A
Low
Report
Form 4 CareDx, Inc. For: Jun 13 Filed by: TORRES ARTHUR A
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
17.3%
4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%
5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%
1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%
4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%
9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%
10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%
5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%
3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%
6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%
4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%
5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%
1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%
4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%
9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%
10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%
5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%
3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%
6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%
TOP News Decliners
3/16
Form 4 CareDx, Inc. For: Mar 16 Filed by: Maag Peter
-19.3%
7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%
8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%
10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%
11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%
3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%
6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%
8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%
7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%
10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%
7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%
8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%
10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%
11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%
3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%
6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%
8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%
7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%
10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: